The recent Supreme Court decision overruling Chevron deference has created a significant impact across numerous industries, including healthcare. This ruling has stripped some of the latitude and autonomy that federal agencies previously had to define, interpret, and enforce regulations. As a
Cellectar Biosciences has recently unveiled its strategic initiatives for 2025, showcasing their ambitious plans at the Biotech Showcase during the JP Morgan Healthcare Conference, aiming to transform cancer treatment. The company is focused on advancing its lead radiotherapeutic agent, iopofosine
A recent investigation led by the U.S. Senate Committee on the Budget has raised alarm over the deteriorating care in hospitals owned by private equity (PE) firms across the United States. This bipartisan probe, spearheaded by Senators Chuck Grassley and Sheldon Whitehouse, delved into the growing
Health workers in Turkey’s primary health system have launched a five-day protest against new regulations that prioritize commercialization and profit over patient care. Beginning on January 6, the protests have included rallies across Turkey and culminated in a nationwide healthcare strike to e
The U.S. Food and Drug Administration (FDA) has recently issued new guidelines to tackle the issue of racial bias in devices that measure oxygen levels in the blood, known as pulse oximeters. These guidelines arose from the importance of this issue during the COVID-19 pandemic, when inaccuracies in
In a groundbreaking move to ensure patient safety and device efficacy, the FDA has recently issued comprehensive guidance on the lifecycle management of AI-enabled medical devices, emphasizing the importance of proactive monitoring and long-term performance management. This directive addresses the
